Recent News

The Orphan Drug Act and the National Organization for Rare Disorders Bring Attention and Funding to Rare Diseases

January 25, 2018

Testing and developing new drugs and treatments for an illness is a costly endeavor, but drug companies thrive in this business by being able to sell medication to the sick[…]

Read More

Gene Therapy and DNA Sequencing for Malignant Mesothelioma

January 19, 2018

Genes are the basic unit of DNA that creates unique proteins used for specific cellular function. The expression of that gene creates an effect and if a gene cannot make[…]

Read More

Multimodality Therapy in Pleural Mesothelioma

January 11, 2018

Even though there is no cure for mesothelioma, there are many different treatment options for those suffering from this almost always fatal cancer. Palliative therapy has been successful in lessening[…]

Read More

An Inaccurate Mesothelioma Prognosis Can Result in Wrong Treatment

January 5, 2018

Mesothelioma is not easy to diagnose. Symptoms often mimic other ailments and patients often do not make the connection between asbestos exposure and their illness. Once mesothelioma is diagnosed, patients[…]

Read More

Screening for Mesothelioma: Detecting Mesothelioma Before Symptoms

December 26, 2017

Diagnosing mesothelioma in the early stages has proven to be difficult. Biomarkers and diagnostic procedures are the most common way of determining this cancer’s existence, but if mesothelioma could be[…]

Read More

Risk Factors From Intraperitoneal Chemotherapy Could Be Determined By Early Biomarker

December 19, 2017

Peritoneal mesothelioma is an extremely rare form of mesothelioma that affects the abdominal lining, or peritoneum.  Caused by asbestos exposure, peritoneal mesothelioma can be difficult to diagnose because symptoms are[…]

Read More

ONCOS-102 Passes Safety Evaluation in Phase I Clinical Trials, Phase II Clinical Trial Recommended

December 12, 2017

A new immunotherapy developed by Targovax has recently passed Phase I clinical trials and is set to begin Phase II evaluation of this new treatment that may help those suffering[…]

Read More

Legitimate Data and Research is Required for Treatment Approval

December 7, 2017

For cancer patients who have little success with traditional chemotherapy and radiation treatments, immunotherapy treatments are becoming known alternatives – working with the body’s own immune system to become stronger[…]

Read More

Pleural Catheter vs. Pleurodesis

December 1, 2017

Symptoms for pleural mesothelioma are typically centered on lung function breathing, with shortness of breath (dyspnea), pleural effusion (fluid build-up), and pain in the chest being the primary indicators.  There[…]

Read More

Funding Needed for Lung Cancer Awareness and Research – How You Can Help

November 29, 2017

As November draws to a close, so does Lung Cancer Awareness Month, but that doesn’t mean we should forget about this devastating cancer that affects hundreds of thousands of people[…]

Read More